228 related articles for article (PubMed ID: 20304217)
21. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
[TBL] [Abstract][Full Text] [Related]
22. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
[TBL] [Abstract][Full Text] [Related]
24. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
[TBL] [Abstract][Full Text] [Related]
25. Liver transplantation results for hepatocellular carcinoma in Chile.
Gabrielli M; Vivanco M; Hepp J; Martínez J; Pérez R; Guerra J; Arrese M; Figueroa E; Soza A; Yáñes R; Humeres R; Rios H; Palacios JM; Zapata R; Sanhueza E; Contreras J; Rencoret G; Rossi R; Jarufe N
Transplant Proc; 2010; 42(1):299-301. PubMed ID: 20172336
[TBL] [Abstract][Full Text] [Related]
26. Bridge therapy in hepatocellular carcinoma before liver transplantation: the experience of two Chilean centers.
Vivanco M; Gabrielli M; Jarufe N; Humeres R; Rios H; Palacios JM; Zapata R; Sanhueza E; Contreras J; Rencore G; Rossi R; Martínez J; Pérez R; Guerra J; Arrese M; Figueroa E; Soza A; Yáñes R; Hepp J
Transplant Proc; 2010; 42(1):296-8. PubMed ID: 20172335
[TBL] [Abstract][Full Text] [Related]
27. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
[TBL] [Abstract][Full Text] [Related]
28. Sorafenib treatment for recurrent hepatocellular carcinoma after liver transplantation.
Sotiropoulos GC; Nowak KW; Fouzas I; Vernadakis S; Kykalos S; Klein CG; Paul A
Transplant Proc; 2012 Nov; 44(9):2754-6. PubMed ID: 23146514
[TBL] [Abstract][Full Text] [Related]
29. Pretransplantation α-fetoprotein slope and milan criteria: strong predictors of hepatocellular carcinoma recurrence after transplantation.
Dumitra TC; Dumitra S; Metrakos PP; Barkun JS; Chaudhury P; Deschênes M; Paraskevas S; Hassanain M; Tchervenkov JI
Transplantation; 2013 Jan; 95(1):228-33. PubMed ID: 23222895
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
[TBL] [Abstract][Full Text] [Related]
31. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
[TBL] [Abstract][Full Text] [Related]
32. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
33. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
34. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
35. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases].
Chen GH; Yang Y; Lu MQ; Cai CJ; He XS; Zhu XF; Xu C; Li H; Huang JF
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):413-6. PubMed ID: 15144669
[TBL] [Abstract][Full Text] [Related]
36. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
37. Impact of model for end-stage liver disease score on long-term survival following liver transplantation for hepatocellular carcinoma.
Roma J; Balbi E; Pacheco-Moreira L; Zyngier I; Araujo A; Agoglia L; Steinbruck K; Velaverde LG; Martinho JM
Transplant Proc; 2012 Oct; 44(8):2423-7. PubMed ID: 23026611
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria.
Sieghart W; Wang X; Schmid K; Pinter M; König F; Bodingbauer M; Wrba F; Rasoul-Rockenschaub S; Peck-Radosavljevic M
J Hepatol; 2011 Jan; 54(1):89-97. PubMed ID: 20970216
[TBL] [Abstract][Full Text] [Related]
39. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution.
Shah SA; Cleary SP; Tan JC; Wei AC; Gallinger S; Grant DR; Greig PD
Ann Surg Oncol; 2007 Sep; 14(9):2608-14. PubMed ID: 17522942
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
